Total Funding
73
66
Total FundingGrant raised
Growth Score
-3 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
26101
Seraxis is a privately owned biotechnology company.
Jerry Baty: Board Of Directors, Compensation Committee MemberPast Role: AxioMed Spine, Chief Financial Officer- Carole Welsch: Co-Founder & Chief Business Officer
About the Company
Seraxis is a private biotechnology company launched in March 2013. Incorporated in Singapore and the United States, their GMP lab is located in Germantown, Maryland. Seraxis team of scientists developed novel cell and encapsulation technologies. Their main goal is to bring a practical cell therapy for insulin-dependent diabetes to the clinic and
provide a long term cure to patients that does not require the use of immuno-suppression.
Their corporate structure and strategy is designed to achieve that goal as quickly as possible, while bringing maximum value to their shareholders.
Women Founded
